{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:27:02Z","timestamp":1780385222976,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100024214","name":"Jichi Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004031","name":"Jichi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07070"],"award-info":[{"award-number":["JP21K07070"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcyt.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T18:21:43Z","timestamp":1728152503000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-7913","authenticated-orcid":false,"given":"Masaharu","family":"Tamaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohigashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Masuko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-7857","authenticated-orcid":false,"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.09.007_bib0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/bmt.2013.151","article-title":"Risk factors and organ involvement of chronic GVHD in Japan","volume":"49","author":"Kanda","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bmt.2016.328","article-title":"Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant","volume":"52","author":"Watkins","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0003","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.16182","article-title":"Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study","volume":"188","author":"Bazarbachi","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0005","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1182\/blood-2014-11-613323","article-title":"Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans","volume":"125","author":"Nakasone","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0006","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3324\/haematol.2015.125294","article-title":"Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy","volume":"100","author":"Nakasone","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0007","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.thj.6200117","article-title":"Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants","volume":"2","author":"Gratwohl","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0008","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2003-03-0984","article-title":"Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors","volume":"103","author":"Miklos","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0009","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0010","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.3324\/haematol.2018.199646","article-title":"A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation","volume":"104","author":"Paul","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0011","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood.2023019799","article-title":"Antibody-mediated pathogenesis of chronic GVHD through DBY\/HLA class II complexes and induction of a GVL effect","volume":"142","author":"Umino","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0012","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/bloodadvances.2021006456","article-title":"Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors","volume":"6","author":"Tamaki","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0013","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.jtct.2022.03.018","article-title":"Optimal active anti-thymocyte globulin exposure associated with minimum risk of virus reactivation and comparable acute graft-versus-host disease under adult myeloablative haploidentical peripheral blood stem cell transplantation","volume":"28","author":"Wang","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.seminhematol.2016.01.004","article-title":"Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience","volume":"53","author":"Chang","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0015","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0016","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/ajh.25257","article-title":"Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose","volume":"93","author":"Lee","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0017","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00277-020-04014-5","article-title":"Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience","volume":"99","author":"Zhou","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0018","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2015.06.008","article-title":"HLA-haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide after busulfan-containing reduced-intensity conditioning","volume":"21","author":"Sugita","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0019","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O\u2019Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0021","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","article-title":"Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide","volume":"125","author":"McCurdy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0022","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41409-022-01770-y","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation","volume":"57","author":"Sugita","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0023","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jtct.2022.07.013","article-title":"Characteristics of graft-versus-host disease (GvHD) after post-transplantation cyclophosphamide versus conventional GvHD prophylaxis","volume":"28","author":"Saliba","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0024","first-page":"184.e181","article-title":"Haploidentical versus matched unrelated donor transplants using post-transplantation cyclophosphamide for lymphomas","volume":"29","author":"Mussetti","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3324\/haematol.2016.151779","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant","volume":"102","author":"Ruggeri","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0026","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ajh.25087","article-title":"Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study","volume":"93","author":"Li","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0027","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3324\/haematol.2020.247296","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia","volume":"106","author":"Nagler","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0030","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0031","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0032","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0033","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0034","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0036","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1038\/s41598-023-34442-y","article-title":"Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Tamaki","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0037","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/bloodadvances.2020002007","article-title":"Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT","volume":"4","author":"Matsui","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0038","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/bloodadvances.2019001315","article-title":"New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT","volume":"4","author":"Elfeky","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0039","article-title":"Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"28","author":"Van Benschoten","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0040","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0041","doi-asserted-by":"crossref","first-page":"796349","DOI":"10.3389\/fimmu.2022.796349","article-title":"Post-transplantation cyclophosphamide uniquely restrains alloreactive CD4(+) T-cell proliferation and differentiation after murine MHC-haploidentical hematopoietic cell transplantation","volume":"13","author":"Hadjis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0042","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/tri.13494","article-title":"A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors","volume":"32","author":"Nakamae","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0043","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jcyt.2023.06.002","article-title":"Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients","volume":"25","author":"Tamaki","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0044","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbmt.2017.11.042","volume":"24","author":"Wanquet","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0045","doi-asserted-by":"crossref","first-page":"eabo3420","DOI":"10.1126\/sciimmunol.abo3420","article-title":"Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity","volume":"7","author":"Minnie","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0046","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ajh.26925","article-title":"Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation","volume":"98","author":"Jadi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0047","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.bbmt.2010.03.022","article-title":"Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"16","author":"Larsen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0048","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1182\/blood.2023022343","article-title":"Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens","volume":"143","author":"Fuchs","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0049","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.jtct.2022.01.001","article-title":"Mother donors improve outcomes after HLA haploidentical transplantation: a study by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation","volume":"28","author":"Ruggeri","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0050","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood-2008-01-135285","article-title":"Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor","volume":"112","author":"Stern","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0051","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0052","doi-asserted-by":"crossref","first-page":"1165759","DOI":"10.3389\/fimmu.2023.1165759","article-title":"Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy","volume":"14","author":"Bail\u00e9n","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0053","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1073\/pnas.1222900110","article-title":"H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease","volume":"110","author":"Sahaf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2024.09.007_bib0054","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-3083.2012.02708.x","article-title":"Identification of a novel UTY-encoded minor histocompatibility antigen","volume":"76","author":"Mortensen","year":"2012","journal-title":"Scand J Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924008867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924008867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:09:54Z","timestamp":1762546194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924008867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1465324924008867"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.09.007","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}